What type of container should be used for collecting a fecal elastase sample?

Fecal Elastase Collection Container

Collect fecal elastase in a standard, clean stool collection container without preservatives, ensuring the sample is semi-solid or solid stool—watery or liquid stools should not be used as they produce falsely low results. 1

Critical Collection Requirements

The 2023 AGA guidelines explicitly state that fecal elastase testing must be performed on a semi-solid or solid stool specimen 1. This is the single most important factor for accurate testing, as stool consistency directly impacts result validity.

Why Stool Consistency Matters

• Watery stools cause false-positive results: Research demonstrates that diarrheal samples (>85% water content) produce artificially low elastase values that incorrectly suggest pancreatic insufficiency 2, 3
• In one study, 71% of results ≤199 μg/g in watery samples normalized to ≥200 μg/g when repeated with formed stool 3
• The dilutional effect of excess water content is the primary mechanism for these false results 4, 2

Practical Collection Instructions

Container Type

• Use a plain, clean stool collection container (standard laboratory specimen container)
• No special preservatives or stabilizers are required for fecal elastase testing
• The sample should be frozen immediately at -20°C or -80°C if not analyzed promptly 5

Sample Requirements

• Only collect semi-solid or solid stool
• If the patient produces watery diarrhea, do not collect the sample—wait until stool consistency improves
• Approximately 0.2g of stool is sufficient for analysis 5

Common Pitfalls to Avoid

The most critical error is testing watery stool samples, which leads to:

• Inappropriate diagnosis of exocrine pancreatic insufficiency
• Unnecessary initiation of pancreatic enzyme replacement therapy (PERT)
• Delayed diagnosis of the true cause of diarrhea 3

Some laboratories have changed their reporting practices to not report fecal elastase values ≤199 μg/g from watery samples, instead requesting repeat collection with formed stool 3. This approach has proven clinically safe and reduces inappropriate diagnoses.

Additional Considerations

• Testing can be performed while the patient is on PERT 1—no need to discontinue therapy before collection
• Results ≥200 μg/g in watery samples are reliable and can exclude pancreatic insufficiency 3
• Only results <200 μg/g in watery samples are unreliable and require repeat testing with formed stool